Диссертация (1140944), страница 17
Текст из файла (страница 17)
2003 Dec1;420(1):176-84.11918 Aroor AR, Mandavia CH, Sowers JR. / Insulin resistance and heart failure:molecularmechanisms//HeartFailClin.2012Oct;8(4):609-17.doi:10.1016/j.hfc.2012.06.00519 Asrar ul Haq M, Mutha V, Rudd N, Wong, C. / Diabetic cardiomyopathy—Whatdo we know about it? // World Journal of Cardiovascular Diseases, 2013, 3, 26-32.doi: 10.4236/wjcd.2013.35A00520 Aukrust P, Gullestad L, Lappegård KT, et al. / Complement activation in patientswith congestive heart failure: effect of high-dose intravenous immunoglobulintreatment // Circulation. 2001 Sep 25;104(13):1494-500.21 Barbagallo M, Dominguez LJ / Magnesium and type 2 diabetes // World J Diabetes.2015 Aug 25;6(10):1152-7. doi: 10.4239/wjd.v6.i10.115222 Basseri S, Austin RC.
/ Endoplasmic reticulum stress and lipid metabolism:mechanisms and therapeutic potential // Biochem Res Int. 2012;2012:841362. doi:10.1155/2012/84136223 Bauters C, Lamblin N, McFadden EP, Van Bell E, Millaire A, DeGroote P. /Influence of diabetes mellitus on heart failure risk and outcome // CardiovascDiabetol. 2003 Jan 8;2:1. doi: 10.1186/1475-2840-2-124 Belfki H, Ben Ali S, Bougatef S, et al.
/ Association Between C-Reactive Proteinand Type 2 Diabetes in a Tunisian Population//Inflammation. 2012Apr;35(2):684-9. doi: 10.1007/s10753-011-9361-125 Black S, Kushner I, Samols D. / C-reactive protein // J Biol Chem. 2004 Nov19;279(47):48487-90. doi: 10.1074/jbc.R40002520026 Borradaile NM, Han X, Harp JD, Gale SE, Ory DS, Schaffer JE. / Disruption ofendoplasmic reticulum structure and integrity in lipotoxic cell death // J Lipid Res.2006 Dec;47(12):2726-37.
doi: 10.1194/jlr.M600299-JLR20027 Bosmans JL, Holvoet P, Dauwe SE, et al. / Oxidative modification of low-densitylipoproteins and the outcome of renal allografts at 1 1/2 years // Kidney Int. 2001Jun;59(6):2346-56. doi: 10.1046/j.1523-1755.2001.00752.x12028 Boudina S, Abel ED.
/ Diabetic cardiomyopathy revisited // Circulation. 2007 Jun26;115(25):3213-23. doi: 10.1161/CIRCULATIONAHA.106.67959729 Boudina S, Abel ED. / Diabetic cardiomyopathy, causes and effects // Rev EndocrMetab Disord. 2010 Mar;11(1):31-9. doi: 10.1007/s11154-010-9131-730 Brooks BA, Franjic B, Ban CR, Swaraj K, Yue DK, Celermajer DS, et al.
/Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes //Diabetes Obes Metab 2008;10(9): 739–46. doi: 10.1111/j.1463-1326.2007.00803.x31 Ceriello A, Motz E. / Is oxidative stress the pathogenic mechanism underlyinginsulin resistance, diabetes, and cardiovascular disease? The common soilhypothesis revisited // Arterioscler Thromb Vasc Biol. 2004 May;24(5):816-23.doi: 10.1161/01.ATV.0000122852.22604.7832 Chan JC, Malik V, Jia W et al. / Diabetes in Asia: epidemiology, risk factors, andpathophysiology//JAMA.2009May27;301(20):2129-40.doi:10.1001/jama.2009.726.33 Chang MK, Binder CJ, Torzewski M, Witztum JL. / C-reactive protein binds toboth oxidized LDL and apoptotic cells through recognition of a common ligand:Phosphorylcholine of oxidized phospholipids // Proc Natl Acad Sci U S A.
2002Oct 1;99(20):13043-8. doi: 10.1073/pnas.19239969934 Chatauret N, Favreau F, Giraud S, et al. / Diet-induced increase in plasma oxidizedLDL promotes early fibrosis in a renal porcine auto-transplantation model // JTransl Med. 2014 Mar 22;12:76. doi: 10.1186/1479-5876-12-7635 Chen H., Li D., Sawamura T., Inoue K., Mehta J. L. / Upregulation of LOX-1expression in aorta of hypercholesterolemic rabbits: Modulation by losartan //Biochemical and Biophysical Research Communications.
2000;276(3):1100–1104.doi: 10.1006/bbrc.2000.353236 Chen J, Zhang Z, Cai L. / Diabetic Cardiomyopathy and Its Prevention by Nrf2:CurrentStatus//Diabetes10.4093/dmj.2014.38.5.337MetabJ.2014Oct;38(5):337-45.doi:12137 Chen L, Magliano DJ, Zimmet PZ. / The worldwide epidemiology of type 2diabetes mellitus-present and future perspectives // Nat Rev Endocrinol. 2011 Nov8;8(4):228-36. doi: 10.1038/nrendo.2011.183.38 Chen M, Inoue K, Narumiya S, Masaki T, Sawamura T. / Requirements of basicamino acid residues within the lectin-like domain of LOX-1 for the binding ofoxidized low-density lipoprotein // FEBS Lett. 2001 Jun 22;499(3):215-9.39 Chen M, Nagase M, Fujita T, et al. / Diabetes enhances lectin-like oxidized LDLreceptor-1 (LOX-1) expression in the vascular endothelium: possible role of LOX-1ligand and AGE // Biochem Biophys Res Commun.
2001;287:962–968. doi:10.1006/bbrc.2001.567440 Chen M, Narumiya S, Masaki T, Sawamura T. / Conserved C-terminal residueswithin the lectin-like domain of LOX-1 are essential for oxidized low-densitylipoprotein binding // Biochem J. 2001 Apr 15;355(Pt 2):289-96.41 Christlieb AR, Long R, Underwood RH. / Renin-angiotensin-aldosterone system,electrolyte homeostasis and blood pressure in alloxan diabetes // Am J Med Sci.1979 May-Jun;277(3):295-303.42 Cockcroft JR., Webb DJ, Wilkinson IB. / Arterial stiffness, hypertension anddiabetes mellitus // J Hum Hypertens.
2000 Jun;14(6):377-80.43 Comert M, Tekin IO, Acikgoz S, et al. / Experimental bile-duct ligation resulted inaccumulation of oxidized low-density lipoproteins in BALB/c mice liver // JGastroenterolHepatol.2004Sep;19(9):1052-7.doi:10.1111/j.1440-1746.2004.03400.x44 Cominacini L, Pasini AF, Garbin U, et al.
/ Oxidized low density lipoprotein (oxLDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation ofNF-kappaB through an increased production of intracellular reactive oxygenspecies//JBiolChem.2000Apr28;275(17):12633-8.doi:10.1074/jbc.275.17.1263345 Cominacini L, Rigoni A, Pasini AF, et al. / The binding of oxidized low densitylipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration122of nitric oxide in endothelial cells through an increased production of superoxide //J Biol Chem. 2001 Apr 27;276(17):13750-5.
doi: 10.1074/jbc.M01061220046 Danaei G, Finucane MM, Lu Y, et al. / National, regional, and global trends infasting plasma glucose and diabetes prevalence since 1980: systematic analysis ofhealth examination surveys and epidemiological studies with 370 country-years and2.7 million participants // Lancet. 2011 Jul 2;378(9785):31-40. doi: 10.1016/S01406736(11)60679-X.47 Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. / Metabolic syndrome: acomprehensive perspective based on interactions between obesity, diabetes, andinflammation // Circulation.
2005 Mar 22;111(11):1448-54.48 Devereux RB, Roman MJ, Paranicas M, et al. / Impact of diabetes on cardiacstructure and function: the strong heart study // Circulation. 2000 May16;101(19):2271-6.49 Dhalla NS, Liu X, Panagia V, Takeda N. / Subcellular remodeling and heartdysfunction in chronic diabetes // Cardiovasc Res. 1998 Nov;40(2):239-47.50 Di Bello V, Talarico L, Picano E, et al. / Increased echodensity of myocardial wallin the diabetic heart: an ultrasound tissue characterization study // J Am CollCardiol. 1995 May;25(6):1408-15.51 Díez J. / Mechanisms of cardiac fibrosis in hypertension // J Clin Hypertens(Greenwich).
2007 Jul;9(7):546-50. Doi: 10.1111/j.1524-6175.2007.06626.x52 Drapkina OM, Gegenava BB, Ivashkin VT. / Matrix metalloproteinases incardiology practice // IJRSR. 2015 Aug; 6(8): 5672-9.53 Du Bois D, Du Bois EF. / A formula to estimate the approximate surface area ifheight and weight be known. 1916 // Nutrition. 1989 Sep-Oct;5(5):303-11;discussion 312-3.54 Evans JD. / Straightforward Statistics for the Behavioral Sciences // Pacific Grove:Brooks/Cole Pub. Co, 1996.12355 Falcão-Pires I, Leite-Moreira AF. / Diabetic cardiomyopathy: understanding themolecular and cellular basis to progress in diagnosis and treatment // Heart FailRev. 2012 May;17(3):325-44.
doi: 10.1007/s10741-011-9257-z56 Fang ZY, Prins JB, Marwick TH. / Diabetic cardiomyopathy: evidence,mechanisms, and therapeutic implications // Endocr Rev. 2004 Aug;25(4):543-67.doi: 10.1210/er.2003-001257 Fang ZY, Schull-Meade R, Leano R, Mottram PM, Prins JB, Marwick TH. /Screening for heart disease in diabetic subjects // Am Heart J 2005;149(2):349–54.doi: 10.1016/j.ahj.2004.06.02158 Fang ZY, Yuda S, Anderson V, Short L, Case C, Marwick TH.
/ Echocardiographicdetection of early diabetic myocardial disease // J Am Coll Cardiol. 2003 Feb19;41(4):611-7.59 Fein FS, Sonnenblick EH. / Diabetic cardiomyopathy // Prog Cardiovasc Dis. 1985Jan-Feb;27(4):255-70.60 Fiordaliso F, Cuccovillo I, Bianchi R, et al. / Cardiovascular oxidative stress isreduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes// Life Sci. 2006 Jun 6;79(2):121-9. doi: 10.1016/j.lfs.2005.12.03661 Fiordaliso F, Li B, Latini R, Sonnenblick EH, Anversa P, Leri A, Kajstura J. /Myocyte death in streptozotocin-induced diabetes in rats in angiotensin IIdependent // Lab Invest.
2000 Apr;80(4):513-27.62 Frustaci A, Kajstura J, Chimenti C, et al. / Myocardial cell death in human diabetes// Circ Res. 2000 Dec 8;87(12):1123-32.63 Fujita Y, Kakino A, Nishimichi N, Yamaguchi S, Sato Y, Machida S, et al. /Oxidized LDL receptor LOX-1 binds to C-reactive protein and mediates itsvasculareffects//ClinChem.2009Feb;55(2):285-94.doi:10.1373/clinchem.2008.11975064 Fujita Y, Yamaguchi S, Kakino A, et al. / Lectin-like Oxidized LDL Receptor 1 IsInvolved in CRP-Mediated Complement Activation // Clin Chem. 2011Oct;57(10):1398-405. doi: 10.1373/clinchem.2011.16862512465 Gabay C, Kushner I.
/ Acute-phase proteins and other systemic responses toinflammation//NEnglJMed.1999Feb11;340(6):448-54.doi:10.1056/NEJM19990211340060766 Giorda R, Rudert WA, Vavassori C, Chambers WH, Hiserodt JC, Trucco M. /NKR-P1, a signal transduction molecule on natural killer cells // Science. 1990 Sep14;249(4974):1298–130067 Gorman AM, Healy SJ, Jäger R, Samali A. / Stress management at the ER:Regulators of ER stressinduced apoptosis // Pharmacol Ther.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
